Vertex Pharmaceuticals (VRTX) shares are climbing, up 28% in 2023. Consistent buy pressure is lifting the shares.
Want an edge in trading? Follow the Big Money.
What’s Big Money? Said simply, it’s when a stock rises due to institutional demand. Top stocks tend to attract savvy investors.
You see, fund managers are always looking to bet on the next outperforming stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way.
The 1-year action tells the story. Each green bar signals unusual increasing volumes in VRTX shares, pushing the stock higher. We believe this to be institutional demand:
Few stocks have charts this strong. Recent green bars suggest healthy demand. But, what about the fundamental story?
Next, I want to make sure the fundamental story is healthy too. As you can see, VRTX has had positive sales & EPS growth in recent years:
Source: FactSet
Marrying great fundamentals with our proprietary Big Money software has found some big winning stocks over the long-term.
Check this out. Vertex Pharmaceuticals has been a top-rated stock at MAPsignals. That means the stock has had buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.
It’s made the rare Top 20 report numerous times. The blue bars below shows when VRTX was a top pick:
Tracking unusual volumes reveals the power of the MAPsignals process.
Don’t fight the Big Money!
The VRTX rally has been in place all year. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.
Disclosure: the author holds no position in VRTX at the time of publication.
If you want to take your investing to the next level, learn more about the MAPsignals process here.
Lucas is a well-versed equity investor and educator. He currently is co-founder of research and analytics firm, MAPsignals.com, which focuses on finding outlier stocks by following the Big Money.